Mylan's Acquisition of Matrix


Mylan's Acquisition of Matrix
Case Code: BSTR279
Case Length: 20 Pages
Period: 2005-2007
Pub Date: 2008
Teaching Note: Not Available
 Price: Rs.400
Organization: Mylan, Inc., Matrix Laboratories Ltd.
Industry: Pharma and Biotech
Countries: USA; India; Global
Themes: Mergers, Acquisitions, Strategic Alliances, Growth Strategy
Mylan's Acquisition of Matrix
Abstract Case Intro 1 Case Intro 2 Excerpts

Background Note

Mylan
Mylan was the second-largest US generic drug maker as of 2006. The company was headquartered in West Virginia, USA, and was involved in developing, licensing, manufacturing, marketing, and distributing many generic and proprietary drugs. The company primarily focused on solid oral dosage generic drugs...

Matrix
Matrix, a listed Indian pharmaceutical company, was an API manufacturer established in February 2001. It was the world's second-largest manufacturer of APIs in terms of DMF filing. Its core business was to manufacture APIs and solid oral dosage forms...

Buy this case study (Please select any one of the payment options)

Price: Rs.400
 Price: Rs.400
 PayPal (9 USD)

Custom Search